End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.78 CNY | +1.92% | -2.77% | -8.99% |
03:03pm | Fosun Pharma Unit’s New Drug Application for CMV, HSV Drug Accepted by Chinese Regulator | MT |
Apr. 08 | China Accepts New Drug Applications for Fosun Pharma's Iron Overload Syndrome Drugs | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.99% | 7.35B | |
+28.53% | 673B | |
+24.81% | 551B | |
-8.08% | 348B | |
+14.93% | 317B | |
+5.79% | 288B | |
+2.47% | 210B | |
-0.02% | 204B | |
-9.98% | 195B | |
-11.57% | 145B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Chinese Regulators OK Fosun Pharma Arm's Clinical Trials for Lymphoma Treatment